These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2993980)

  • 21. Studies on the Factor VIII/von Willebrand factor antigen on human platelets.
    Coller BS; Hirschman RJ; Gralnick HR
    Thromb Res; 1975 Jun; 6(6):469-80. PubMed ID: 1098217
    [No Abstract]   [Full Text] [Related]  

  • 22. [Functional significance of intra-platelet factor VIII-related antigen].
    Grignani G; Piovella F; Malamani GD; Cattaneo G
    Boll Soc Ital Biol Sper; 1977 Sep; 53(17):1489-94. PubMed ID: 75736
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Budde U
    Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acquired Von Willebrand's disease. A case report].
    Ercoreca L; Lucía JF; Raichs A; Palomera L
    Sangre (Barc); 1982; 27(3):397-406. PubMed ID: 6984231
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration.
    Bennett A; Cameron JS
    Clin Nephrol; 1987 Apr; 27(4):182-8. PubMed ID: 3107859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor.
    Inbal A; Kornbrot N; Harrison P; Randi AM; Sadler JE
    Thromb Haemost; 1993 Dec; 70(6):1058-62. PubMed ID: 8165601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased platelet sensitivity to ristocetin is predicted by the binding characteristics of a GPIb/IX determinant.
    Miller JL; Hustad KO; Kupinski JM; Lyle VA; Kunicki TJ
    Br J Haematol; 1990 Mar; 74(3):313-9. PubMed ID: 1692230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report of the Working Party on Factor VIII Related Antigens. Addendum: the relationship between ristocetin co-factor activity (VIIIR:Cof) and Factor VIII related antigen (VIIIR:Ag).
    Nilsson IM; Peake IR; Bloom AL; Meyer D; Veltkamp J; Green D
    Thromb Haemost; 1980 Jun; 43(2):167-8. PubMed ID: 6779396
    [No Abstract]   [Full Text] [Related]  

  • 29. Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease.
    Murata M; Fukuyama M; Satoh K; Fujimura Y; Yoshioka A; Takahashi H; Handa M; Kawai Y; Watanabe K; Ikeda Y
    J Clin Invest; 1993 Sep; 92(3):1555-8. PubMed ID: 8376606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the mechanism of ristocetin-induced platelet aggregation: binding of factor VIII to platelets.
    Schneider-Trip MD; Jenkins CS; Kahlé LH; Sturk A; ten Cate JW
    Br J Haematol; 1979 Sep; 43(1):99-112. PubMed ID: 508625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Platelet aggregation caused by ristocetin--its implication and action mechanism].
    Izuchi Y
    Nihon Rinsho; 1978 Dec; 36(12):3848-56. PubMed ID: 372624
    [No Abstract]   [Full Text] [Related]  

  • 32. Factor-VIII-related antigen in platelets.
    Howard MA; Montgomery DC; Hardisty RM
    Thromb Res; 1974 May; 4(5):617-24. PubMed ID: 4545781
    [No Abstract]   [Full Text] [Related]  

  • 33. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired von Willebrand's syndrome in the course of Waldenström's disease.
    Mazurier C; Parquet-Gernez A; Descamps J; Bauters F; Goudemand M
    Thromb Haemost; 1980 Dec; 44(3):115-8. PubMed ID: 6781094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ability of vancomycin-group antibiotics to induce or to inhibit thrombocyte agglutination].
    Rák K; Boda Z; Sztaricskai F
    Antibiotiki; 1980 Aug; 25(8):595-606. PubMed ID: 6250464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ristocetin and von Willebrand factor analysis.
    Light J; Williams CE; Entwistle MB
    Med Lab Sci; 1987 Jul; 44(3):272-9. PubMed ID: 3501515
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: Variations in quantitative ristocetin platelet aggregation (RPA) with time after platelet rich plasma (PRP) preparation: association with alteration in pH.
    Coller BS; Gralnick HR
    Thromb Diath Haemorrh; 1975 Nov; 34(2):581-2. PubMed ID: 809
    [No Abstract]   [Full Text] [Related]  

  • 39. Sorting out heightened interactions between platelets and von Willebrand factor. "IIB or not IIB?" is becoming an increasingly answerable question in the molecular era.
    Miller JL
    Am J Clin Pathol; 1991 Dec; 96(6):681-3. PubMed ID: 1746485
    [No Abstract]   [Full Text] [Related]  

  • 40. The von Willebrand syndrome.
    Bloom AL
    Semin Hematol; 1980 Oct; 17(4):215-27. PubMed ID: 6160617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.